151 related articles for article (PubMed ID: 22285925)
21. pZ402, an improved SV40-based shuttle vector containing a T-antigen mutant unable to interact with wild-type p53.
Kraus E; Strong LC; Tainsky MA
Gene; 1998 May; 211(2):229-34. PubMed ID: 9602136
[TBL] [Abstract][Full Text] [Related]
22. [Construction of a hepatoma-targeting vector of adeno-associated virus containing human alpha-fetoprotein promoter and wild p53 gene in gene therapy of liver cancer].
Cheng J; Leng X; Peng J
Zhonghua Yi Xue Za Zhi; 2000 Jun; 80(6):461-3. PubMed ID: 11798803
[TBL] [Abstract][Full Text] [Related]
23. Anti-tumor effect of adenoviral vector-mediated p53 gene transfer on the growth of canine osteosarcoma xenografts in nude mice.
Kanaya N; Yazawa M; Goto-Koshino Y; Mochizuki M; Nishimura R; Ohno K; Sasaki N; Tsujimoto H
J Vet Med Sci; 2011 Jul; 73(7):877-83. PubMed ID: 21350316
[TBL] [Abstract][Full Text] [Related]
24. Integrative genomics revealed RAI3 is a cell growth-promoting gene and a novel P53 transcriptional target.
Wu Q; Ding W; Mirza A; Van Arsdale T; Wei I; Bishop WR; Basso A; McClanahan T; Luo L; Kirschmeier P; Gustafson E; Hernandez M; Liu S
J Biol Chem; 2005 Apr; 280(13):12935-43. PubMed ID: 15659406
[TBL] [Abstract][Full Text] [Related]
25. Gene regulation by temperature-sensitive p53 mutants: identification of p53 response genes.
Buckbinder L; Talbott R; Seizinger BR; Kley N
Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10640-4. PubMed ID: 7938006
[TBL] [Abstract][Full Text] [Related]
26. Adenoviral p53 gene therapy promotes heat-induced apoptosis in a nasopharyngeal carcinoma cell line.
Qi V; Weinrib L; Ma N; Li JH; Klamut H; Liu FF
Int J Hyperthermia; 2001; 17(1):38-47. PubMed ID: 11212879
[TBL] [Abstract][Full Text] [Related]
27. Antitumor effect of adenovirus-mediated p53 family gene transfer on osteosarcoma cell lines.
Oshima Y; Sasaki Y; Negishi H; Idogawa M; Toyota M; Yamashita T; Wada T; Nagoya S; Kawaguchi S; Yamashita T; Tokino T
Cancer Biol Ther; 2007 Jul; 6(7):1058-66. PubMed ID: 17568187
[TBL] [Abstract][Full Text] [Related]
28. Development of a p53 responsive GFP reporter; identification of live cells with p53 activity.
Zhang WW; Labrecque S; Azoulay E; Dudley R; Matlashewski G
J Biotechnol; 2001 Nov; 84(1):79-86. PubMed ID: 11035191
[TBL] [Abstract][Full Text] [Related]
29. Bicistronic transfer of CDKN2A and p53 culminates in collaborative killing of human lung cancer cells in vitro and in vivo.
Xande JG; Dias AP; Tamura RE; Cruz MC; Brito B; Ferreira RA; Strauss BE; Costanzi-Strauss E
Gene Ther; 2020 Feb; 27(1-2):51-61. PubMed ID: 31439890
[TBL] [Abstract][Full Text] [Related]
30. Combined radiation and p53 gene therapy of malignant glioma cells.
Badie B; Goh CS; Klaver J; Herweijer H; Boothman DA
Cancer Gene Ther; 1999; 6(2):155-62. PubMed ID: 10195882
[TBL] [Abstract][Full Text] [Related]
31. Adenovirus-mediated transfer of the p53 family genes, p73 and p51/p63 induces cell cycle arrest and apoptosis in colorectal cancer cell lines: potential application to gene therapy of colorectal cancer.
Sasaki Y; Morimoto I; Ishida S; Yamashita T; Imai K; Tokino T
Gene Ther; 2001 Sep; 8(18):1401-8. PubMed ID: 11571580
[TBL] [Abstract][Full Text] [Related]
32. Generation of a genome scale lentiviral vector library for EF1α promoter-driven expression of human ORFs and identification of human genes affecting viral titer.
Škalamera D; Dahmer M; Purdon AS; Wilson BM; Ranall MV; Blumenthal A; Gabrielli B; Gonda TJ
PLoS One; 2012; 7(12):e51733. PubMed ID: 23251614
[TBL] [Abstract][Full Text] [Related]
33. Induction of apoptosis in human esophageal cancer cells by sequential transfer of the wild-type p53 and E2F-1 genes: involvement of p53 accumulation via ARF-mediated MDM2 down-regulation.
Itoshima T; Fujiwara T; Waku T; Shao J; Kataoka M; Yarbrough WG; Liu TJ; Roth JA; Tanaka N; Kodama M
Clin Cancer Res; 2000 Jul; 6(7):2851-9. PubMed ID: 10914734
[TBL] [Abstract][Full Text] [Related]
34. Urocanic acid-modified chitosan-mediated p53 gene delivery inducing apoptosis of human hepatocellular carcinoma cell line HepG2 is involved in its antitumor effect in vitro and in vivo.
Wang W; Yao J; Zhou JP; Lu Y; Wang Y; Tao L; Li YP
Biochem Biophys Res Commun; 2008 Dec; 377(2):567-572. PubMed ID: 18929532
[TBL] [Abstract][Full Text] [Related]
35. Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway.
Spina A; Sorvillo L; Di Maiolo F; Esposito A; D'Auria R; Di Gesto D; Chiosi E; Naviglio S
J Cell Physiol; 2013 Jan; 228(1):198-206. PubMed ID: 22674530
[TBL] [Abstract][Full Text] [Related]
36. Repression of p53-dependent sequence-specific transactivation by MEF2c.
Sato H; Tsukada T; Nagayoshi M; Ikawa Y; Aizawa S; Kato MV
Biochem Biophys Res Commun; 1995 Sep; 214(2):468-74. PubMed ID: 7677753
[TBL] [Abstract][Full Text] [Related]
37. The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis.
Maheswaran S; Englert C; Bennett P; Heinrich G; Haber DA
Genes Dev; 1995 Sep; 9(17):2143-56. PubMed ID: 7657166
[TBL] [Abstract][Full Text] [Related]
38. p53 gene transfer does not enhance E2F-1-mediated apoptosis in human colon cancer cells.
Draus JM; Elliott MJ; Atienza C; Stilwell A; Wong SL; Dong Y; Yang H; McMasters KM
Exp Mol Med; 2001 Dec; 33(4):209-19. PubMed ID: 11795482
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
[TBL] [Abstract][Full Text] [Related]
40. Identification of SULF2 as a novel transcriptional target of p53 by use of integrated genomic analyses.
Chau BN; Diaz RL; Saunders MA; Cheng C; Chang AN; Warrener P; Bradshaw J; Linsley PS; Cleary MA
Cancer Res; 2009 Feb; 69(4):1368-74. PubMed ID: 19190338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
